{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:12:26Z","timestamp":1770221546514,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.pharep.2014.06.005","type":"journal-article","created":{"date-parts":[[2014,6,21]],"date-time":"2014-06-21T17:00:25Z","timestamp":1403370025000},"page":"972-975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Concentration of Il-1\u03b2, Il-2, Il-6, TNF\u03b1 in the blood serum in children with generalized epilepsy treated by valproate"],"prefix":"10.1007","volume":"66","author":[{"given":"Barbara","family":"Steinborn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"\u017barowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Winczewska-Wiktor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlena","family":"W\u00f3jcicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"M\u0142odzikowska-Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Losy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2014.06.005_bib0005","series-title":"Pediatric epilepsy. Diagnosis and therapy","author":"Pellock","year":"2008"},{"key":"10.1016\/j.pharep.2014.06.005_bib0010","first-page":"258","article-title":"The role of interleukin-1 in seizures and epilepsy: a critical review","volume":"2","author":"Rijkers","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharep.2014.06.005_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1535-7597.2005.05101.x","article-title":"Inflammation and epilepsy","volume":"1","author":"Vezzani","year":"2005","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.pharep.2014.06.005_bib0020","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain inflammation in epilepsy: experimental and clinical evidence","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2014.06.005_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2008.01490.x","article-title":"Glia as a source of cytokines: implications for neuronal excitability and survival","volume":"49","author":"Vezzani","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2014.06.005_bib0030","first-page":"748","article-title":"New concepts on the role of cytokines in the central nervous system","volume":"150","author":"Jacque","year":"1994","journal-title":"Rev Neurol"},{"key":"10.1016\/j.pharep.2014.06.005_bib0035","first-page":"129","article-title":"Cytokines, epilepsy and epileptic drugs \u2013 is there a mutual influence?","volume":"59","author":"Mlodzikowska-Albrecht","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2014.06.005_bib0040","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbi.2008.03.009","article-title":"The role of cytokines in the pathophysiology of epilepsy","volume":"22","author":"Vezzani","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.pharep.2014.06.005_bib0045","series-title":"Immunologia","first-page":"326","article-title":"Psychoneuroimmunology [in polish]","author":"Stok\u0142osa","year":"2004"},{"key":"10.1016\/j.pharep.2014.06.005_bib0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1196\/annals.1391.022","article-title":"Interleukin-1 system in CNS stress: seizures, fever, and neurotrauma","volume":"1113","author":"Bartfai","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharep.2014.06.005_bib0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2014.06.005_bib0060","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharep.2014.06.005_bib0065","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1007\/s00018-008-8521-4","article-title":"Valproic acid attenuates inflammation in experimental autoimmune neuritis","volume":"65","author":"Zhang","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharep.2014.06.005_bib0070","first-page":"43","article-title":"Neuroimmunopathologic aspects of epilepsy","volume":"8","author":"Evseev","year":"2004","journal-title":"Vestn Ross Akad Med Nauk"},{"key":"10.1016\/j.pharep.2014.06.005_bib0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.50.2.407","article-title":"Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures. Comparison with acute encephalitis\/encephalopathy","volume":"50","author":"Ichiyama","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pharep.2014.06.005_bib0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000097189","article-title":"Effects of interleukin-2 on various models of experimental epilepsy in DBA\/2 mice","volume":"1","author":"De Sarro","year":"1994","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.pharep.2014.06.005_bib0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eplepsyres.2008.07.018","article-title":"Do cytokines have any role in epilepsy?","volume":"82","author":"Sinha","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharep.2014.06.005_bib0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00002018-199308030-00005","article-title":"Immunological adverse effects of anticonvulsants. What is their clinical relevance?","volume":"8","author":"De Ponti","year":"1993","journal-title":"Drug Saf"},{"key":"10.1016\/j.pharep.2014.06.005_bib0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00004850-200511000-00002","article-title":"Effect of valproate on plasma levels of interleukin-6 in healthy male humans","volume":"20","author":"Shiah","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharep.2014.06.005_bib0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1734-1140(11)70402-9","article-title":"Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL-10 and IFN-\u03b3 secretion in epileptic patients: the influence of co-medication","volume":"63","author":"Mathieu","year":"2011","journal-title":"Pharmacol Rep"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:34Z","timestamp":1752611734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2014.06.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1734114014002163"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2014.06.005","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concentration of Il-1\u03b2, Il-2, Il-6, TNF\u03b1 in the blood serum in children with generalized epilepsy treated by valproate","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2014.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}